
OmicsBank is a clinical data infrastructure company. Its platform is deployed within hospital and diagnostic networks across South Asia, Southeast Asia, and the Middle East, turning fragmented, unstructured clinical records into standardized, de-identified, patient-level datasets that research and AI systems can query directly. Its offering spans FHIR, OMOP CDM-structured EHR data, imaging, and genomic, transcriptomic, proteomic, phenomic, and metabolomic datasets and biospecimens - all made available under IRB and ethics committee approval, through an ISO 27001-certified, HIPAA- and GDPR-compliant process. OmicsBank works with pharma companies and frontier AI labs on drug discovery, drug development, and clinical AI.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/25/26 | $2,250,000 | Seed |
Redesign Health | undisclosed |